|
2025
|
Invention
|
Use of roluperidone to treat negative symptoms and disorders, increase neuroplasticity, and promo... |
|
|
Invention
|
Methods of use of cyclic amide derivatives to treat sigma receptor mediated disorders.
Disclosed... |
|
|
Invention
|
(2s)-1-[4-(3,4-dichlorophenyl)piperidin-1-yl]-3-[2-(5-methyl-1,3,4-oxadiazol-2-yl)benzo[b]furan-4... |
|
2024
|
Invention
|
Compositions and methods for treating schizophrenia.
The disclosure provides a novel polymorph o... |
|
|
Invention
|
Roluperidone for the treatment of lysosomal storage disorders and their symptoms. Described herei... |
|
|
Invention
|
Methods of use of cyclic amide derivatives to treat schizophrenia.
Disclosed herein are composit... |
|
|
Invention
|
Methods of use of phenoxypropylamine compounds to treat depression.
Disclosed herein are composi... |
|
|
Invention
|
Sigma ligand compounds and uses thereof.
The present disclosure relates to compounds of Formula ... |
|
|
Invention
|
Use of condensed azacycle compounds for the treatment of lysosomal storage disorders. Described h... |
|
2023
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseas... |
|
|
Invention
|
Use of roluperidone in preventing relapse in schizophrenia patients.
This application pertains t... |
|
|
Invention
|
Use of roluperidone in preventing relapse in schizophrenia patients. This application pertains to... |
|
2022
|
Invention
|
Compositions and methods for treating negative symptoms in non-schizophrenic patients.
The prese... |
|
2021
|
Invention
|
Sigma ligand compounds and uses thereof. The present disclosure relates to compounds of Formula (... |
|
|
Invention
|
Condensed azacycles as sigma ligand compounds and uses thereof. The present disclosure relates to... |
|
2019
|
Invention
|
Methods of using a phenoxypropylamine compound to treat pain. The present disclosure relates to m... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for use in the treatment of neurological... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations acting on the central nervous system; ph... |
|
|
Invention
|
Compositions and methods for treating schizophrenia. The disclosure provides a novel polymorph of... |
|
2018
|
Invention
|
Gastro-resistant controlled release oral dosage forms. This disclosure relates to gastro-resistan... |
|
2017
|
Invention
|
Compositions and methods for treating negative symptoms in non-schizophrenic patients. The presen... |
|
|
Invention
|
(2s)-1-[4-(3,4-dichlorophenyl)piperidin-l-yl]-3-[2-(5-methyl-l,3,4-oxadiazol-2-yl)benzo[b]furan-4... |
|
2015
|
Invention
|
Compositions comprising 2-((1-(2(4-fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-on... |
|
2014
|
G/S
|
Research and development of new products and technology in the field of neuropsychiatric diseases... |
|
|
Invention
|
Use of phenoxypropylamine compounds to treat depression. Disclosed herein are compositions and me... |
|
|
Invention
|
Use of phenoxypropylamine compounds to treat sleep disorders. Disclosed herein are compositions a... |
|
|
Invention
|
Methods of use of phenoxypropylamine compounds to treat depression.
Disclosed herein a... |
|
2011
|
Invention
|
Methods of use of cyclic amide derivatives to treat schizophrenia. Disclosed herein are compositi... |
|
|
Invention
|
Methods of use of cyclic amide derivatives to treat schizophrenia. Herein are described uses of a... |
|
|
Invention
|
Use of cyclic amide derivatives to treat sigma receptor-mediated disorders.
Herein is ... |
|
|
Invention
|
Methods of use of cyclic amide derivatives to treat schizophrenia.
Abstract
Herein... |
